Literature DB >> 17440740

Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.

Ying Wang1, Zhao-Fa Li, Jin He, Yi-Lei Li, Gui-Bin Zhu, Li-Hong Zhang, Yu-Lin Li.   

Abstract

BACKGROUND: Human phosphatases of regenerating liver (PRLs) can induce cell growth, differentiation, and malignant transformation. In this study, we used specific polyclonal antibodies against PRLs to investigate their expression in colonic adenocarcinomas and its correlation with patient gender, age, tumor differentiation, localization, invasion, and metastasis.
MATERIALS AND METHODS: The polyclonal antibodies against PRL-1, PRL-2, and PRL-3 were produced and purified. The expression of PRLs in human colorectal carcinoma cell lines (SW480 and SW620) was examined by Western blotting. We also examined their expression in normal and pathologic tissues from the human colon. The tissues included 49 primary colonic adenocarcinomas, 14 cases with lymph node metastases, 15 colonic adenomas, and 12 normal colon samples. Hematoxylin and eosin staining, immunohistochemistry, and semiquantitative morphological analysis were used to evaluate the sections.
RESULTS: PRLs were widely expressed in SW480 and SW620. PRL-1, PRL-2, and PRL-3 were expressed, respectively, in 16, 10, and 16% of primary colonic adenocarcinomas. In contrast, PRLs were strongly expressed in all lymph node metastases. There were no significant correlations between the expression of PRLs and patient gender, age, tumor differentiation, depth of invasion, or localization of tumor within the different sections of the colon. PRLs were not expressed in normal colon tissues or in colonic adenomas. PRLs were mainly expressed in the cytoplasm and at the cytoplasmic membranes of the colonic adenocarcinoma cells as well as in the endothelial cells and the surrounding smooth muscle cells of larger vessels in the lymph node metastases.
CONCLUSION: Colonic adenocarcinoma cells have the ability to produce PRLs, which may relate to the lymph node metastasis of colonic adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440740     DOI: 10.1007/s00384-007-0303-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  17 in total

1.  Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome.

Authors:  Q Zeng; X Si; H Horstmann; Y Xu; W Hong; C J Pallen
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

2.  Preparation and characterization of monoclonal antibody against protein tyrosine phosphatase PRL-3.

Authors:  Lirong Peng; Yan Li; Ling Meng; Chengchao Shou
Journal:  Hybrid Hybridomics       Date:  2004-02

3.  Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine.

Authors:  R H Diamond; C Peters; S P Jung; L E Greenbaum; B A Haber; D G Silberg; P G Traber; R Taub
Journal:  Am J Physiol       Date:  1996-07

4.  Characterization and genomic mapping of genes and pseudogenes of a new human protein tyrosine phosphatase.

Authors:  Z Zhao; C C Lee; D G Monckton; A Yazdani; M I Coolbaugh; X Li; J Bailey; Y Shen; C T Caskey
Journal:  Genomics       Date:  1996-07-01       Impact factor: 5.736

Review 5.  Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer.

Authors:  S R Johnston
Journal:  Lancet Oncol       Date:  2001-01       Impact factor: 41.316

6.  A 100-kb physical and transcriptional map around the EDH17B2 gene: identification of three novel genes and a pseudogene of a human homologue of the rat PRL-1 tyrosine phosphatase.

Authors:  M Montagna; O Serova; B S Sylla; J Feunteun; G M Lenoir
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

7.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

8.  PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth.

Authors:  R H Diamond; D E Cressman; T M Laz; C S Abrams; R Taub
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

9.  PRL-3 expression in metastatic cancers.

Authors:  Alberto Bardelli; Saurabh Saha; Jason A Sager; Kathy E Romans; Baozhong Xin; Sanford D Markowitz; Christoph Lengauer; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein
Journal:  Clin Cancer Res       Date:  2003-11-15       Impact factor: 12.531

10.  Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration.

Authors:  B A Haber; K L Mohn; R H Diamond; R Taub
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

View more
  22 in total

1.  Tissue-specific alterations of PRL-1 and PRL-2 expression in cancer.

Authors:  Carmen M Dumaual; George E Sandusky; Han Weng Soo; Sean R Werner; Pamela L Crowell; Stephen K Randall
Journal:  Am J Transl Res       Date:  2012-01-05       Impact factor: 4.060

2.  Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.

Authors:  Ru-Tian Hao; Xiao-Hua Zhang; Yi-Fei Pan; Hai-Guang Liu; You-Qun Xiang; Li Wan; Xiu-Ling Wu
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-06       Impact factor: 4.553

Review 3.  Inside the human cancer tyrosine phosphatome.

Authors:  Sofi G Julien; Nadia Dubé; Serge Hardy; Michel L Tremblay
Journal:  Nat Rev Cancer       Date:  2011-01       Impact factor: 60.716

4.  Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis.

Authors:  Yanjun Jiang; Xiao-Qiong Liu; Ashwani Rajput; Liying Geng; Melanie Ongchin; Qi Zeng; Gregory S Taylor; Jing Wang
Journal:  Cancer Res       Date:  2010-11-16       Impact factor: 12.701

5.  Enzyme activity of phosphatase of regenerating liver is controlled by the redox environment and its C-terminal residues.

Authors:  Andria L Skinner; Anthony A Vartia; Todd D Williams; Jennifer S Laurence
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

6.  Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer.

Authors:  Tingting Ren; Beihai Jiang; Xiaofang Xing; Bin Dong; Lirong Peng; Lin Meng; Huiyu Xu; Chengchao Shou
Journal:  Pathol Oncol Res       Date:  2009-02-27       Impact factor: 3.201

7.  A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.

Authors:  Kelley E McQueeney; Joseph M Salamoun; Jennifer G Ahn; Paula Pekic; Isabella K Blanco; Heather L Struckman; Elizabeth R Sharlow; Peter Wipf; John S Lazo
Journal:  FASEB J       Date:  2018-05-10       Impact factor: 5.191

8.  Generation of conditional knockout alleles for PRL-3.

Authors:  Hong Yan; Dong Kong; Xiaomei Ge; Xiang Gao; Xiao Han
Journal:  J Biomed Res       Date:  2011-11

9.  MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1.

Authors:  Chang Zhou; Guobing Liu; Lijing Wang; Yanxia Lu; Li Yuan; Lin Zheng; Fang Chen; Fanli Peng; Xuenong Li
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

10.  Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogene.

Authors:  Krystle T Pagarigan; Bryce W Bunn; Jake Goodchild; Travis K Rahe; Julie F Weis; Leslie J Saucedo
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.